GHRP-2 Reduces Arthritis Inflammation: A GH Secretagogue as an Anti-Inflammatory Drug

GHRP-2 reduced joint inflammation and cartilage destruction in arthritic rats through anti-inflammatory mechanisms including cytokine suppression, demonstrating GH secretagogues' potential for treating inflammatory joint disease.

Granado, Miriam et al.·American journal of physiology. Endocrinology and metabolism·2005·Moderate EvidenceAnimal StudyAnimal Study
RPEP-01038Animal StudyModerate Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

GHRP-2 reduced clinical arthritis scores, joint inflammation, and cartilage destruction in adjuvant-arthritic rats, suppressing pro-inflammatory cytokines (TNF-α, IL-6) — establishing GH secretagogues as anti-inflammatory agents for arthritis treatment.

Key Numbers

How They Did This

animal-study study on ghrp, inflammation.

Why This Research Matters

Relevant for ghrp, inflammation, bone-joint, immune-function.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding GHRP-2 reduced clinical arthritis scores, joint inflammation, and cartilage destruction in adjuvant-arthritic rats, suppressing pro-inflammatory cytok
Evidence Grade:
moderate evidence.
Study Age:
Published in 2005.
Original Title:
Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
Published In:
American journal of physiology. Endocrinology and metabolism, 288(3), E486-92 (2005)
Database ID:
RPEP-01038

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

GHRP-2 Reduces Arthritis Inflammation: A GH Secretagogue as an Anti-Inflammatory Drug

What was found?

GHRP-2 reduced joint inflammation and cartilage destruction in arthritic rats through anti-inflammatory mechanisms including cytokine suppression, demonstrating GH secretagogues' potential for treating inflammatory joint disease.

Read More on RethinkPeptides

Cite This Study

RPEP-01038·https://rethinkpeptides.com/research/RPEP-01038

APA

Granado, Miriam; Priego, Teresa; Martín, Ana I; Villanúa, M Angeles; López-Calderón, Asunción. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.. American journal of physiology. Endocrinology and metabolism, 288(3), E486-92.

MLA

Granado, Miriam, et al. "Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.." American journal of physiology. Endocrinology and metabolism, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Anti-inflammatory effect of the ghrelin agonist growth hormo..." RPEP-01038. Retrieved from https://rethinkpeptides.com/research/granado-2005-antiinflammatory-effect-of-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.